Koninklijke Philips Future Growth

Future criteria checks 3/6

Koninklijke Philips is forecast to grow earnings and revenue by 58.7% and 4.9% per annum respectively. EPS is expected to grow by 60.7% per annum. Return on equity is forecast to be 12.4% in 3 years.

Key information

58.7%

Earnings growth rate

60.7%

EPS growth rate

Medical Equipment earnings growth	18.6%
Revenue growth rate	4.9%
Future return on equity	12.4%
Analyst coverage	Good
Last updated	02 Aug 2024

Recent future growth updates

Koninklijke Philips N.V. Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Jul 31

Recent updates

Koninklijke Philips N.V. Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Jul 31

Improved Revenues Required Before Koninklijke Philips N.V. (AMS:PHIA) Shares Find Their Feet

Jul 29

These 4 Measures Indicate That Koninklijke Philips (AMS:PHIA) Is Using Debt Extensively

Jun 23

Earnings and Revenue Growth Forecasts

ENXTAM:PHIA - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	20,440	1,387	1,627	2,493	14
12/31/2025	19,532	1,149	722	1,473	15
12/31/2024	18,651	62	1,184	1,793	15
6/30/2024	18,133	-555	1,137	1,800	N/A
3/31/2024	18,140	-794	N/A	N/A	N/A
12/31/2023	18,169	-456	1,615	2,259	N/A
9/30/2023	18,529	-609	N/A	N/A	N/A
6/30/2023	18,368	-2,035	12	766	N/A
3/31/2023	18,076	-2,132	N/A	N/A	N/A
12/31/2022	17,827	-1,621	-991	-185	N/A
9/30/2022	17,349	-1,363	N/A	N/A	N/A
6/30/2022	17,194	402	2,893	3,681	N/A
3/31/2022	17,247	491	N/A	N/A	N/A
12/31/2021	17,156	608	4,269	5,032	N/A
9/30/2021	19,669	1,173	N/A	N/A	N/A
6/30/2021	17,703	811	1,921	2,722	N/A
3/31/2021	19,669	1,147	N/A	N/A	N/A
12/31/2020	17,313	991	1,745	2,640	N/A
9/30/2020	19,492	1,142	N/A	N/A	N/A
6/30/2020	18,327	966	1,315	2,294	N/A
3/31/2020	19,490	1,055	N/A	N/A	N/A
12/31/2019	17,147	984	960	1,911	N/A
9/30/2019	19,110	1,354	N/A	N/A	N/A
6/30/2019	18,714	1,452	1,063	2,024	N/A
3/31/2019	18,330	1,381	N/A	N/A	N/A
12/31/2018	18,121	1,303	1,584	2,427	N/A
9/30/2018	17,838	1,022	N/A	N/A	N/A
6/30/2018	17,680	871	1,403	2,232	N/A
3/31/2018	17,687	808	N/A	N/A	N/A
12/31/2017	17,780	814	N/A	2,933	N/A
9/30/2017	17,783	830	N/A	N/A	N/A
6/30/2017	17,792	876	N/A	3,193	N/A
3/31/2017	24,724	1,105	N/A	2,526	N/A
12/31/2016	17,422	788	N/A	3,321	N/A
9/30/2016	19,211	218	N/A	3,164	N/A
6/30/2016	20,890	248	N/A	2,948	N/A
3/31/2016	22,732	365	N/A	1,463	N/A
12/31/2015	16,806	145	N/A	1,135	N/A
9/30/2015	23,685	590	N/A	1,113	N/A
6/30/2015	23,043	228	N/A	1,167	N/A
3/31/2015	22,038	191	N/A	1,472	N/A
12/31/2014	21,391	225	N/A	1,408	N/A
9/28/2014	20,373	437	N/A	1,304	N/A
6/29/2014	20,774	839	N/A	1,240	N/A
3/30/2014	21,437	974	N/A	865	N/A
12/31/2013	21,990	1,031	N/A	844	N/A
9/29/2013	23,231	309	N/A	1,221	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PHIA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: PHIA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PHIA is expected to become profitable in the next 3 years.

Revenue vs Market: PHIA's revenue (4.9% per year) is forecast to grow slower than the Dutch market (9.8% per year).

High Growth Revenue: PHIA's revenue (4.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PHIA's Return on Equity is forecast to be low in 3 years time (12.4%).

Koninklijke Philips Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Koninklijke Philips N.V. Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Price target increased by 7.7% to €25.87

Koninklijke Philips N.V. Provides Earnings Guidance for the Year 2024

Koninklijke Philips N.V. Provides Earnings Guidance for the Year 2023

Recent updates

New major risk - Financial position

Koninklijke Philips N.V. Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Second quarter 2024 earnings: EPS misses analyst expectations

Improved Revenues Required Before Koninklijke Philips N.V. (AMS:PHIA) Shares Find Their Feet

These 4 Measures Indicate That Koninklijke Philips (AMS:PHIA) Is Using Debt Extensively

Royal Philips Zenition 90 Motorized Receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm

Philips Launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

New minor risk - Shareholder dilution

Price target increased by 7.7% to €25.87

New major risk - Financial position

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Here's Why Koninklijke Philips (AMS:PHIA) Has A Meaningful Debt Burden

Koninklijke Philips N.V. to Report Q4, 2024 Results on Feb 03, 2025

Royal Philips Announces New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

Full year 2023 earnings: EPS and revenues miss analyst expectations

Koninklijke Philips N.V. Provides Earnings Guidance for the Year 2024

Royal Philip Introduces the Latest Offering in the Philips Norelco Oneblade Lineup

Lacklustre Performance Is Driving Koninklijke Philips N.V.'s (AMS:PHIA) Low P/S

Does Koninklijke Philips (AMS:PHIA) Have A Healthy Balance Sheet?

Angeion Group Announces Proposed Settlement in Re Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation Class Action

Angeion Group Announces Proposed Settlement in In Re Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation Class Action

Koninklijke Philips N.V. to Report Q2, 2024 Results on Jul 29, 2024

Royal Philips Launches Ultra Lightweight and Flexible MR Smart Fit Coels to Improve Radiology Productivity and Diagnostic confidence at #RSNA23

Koninklijke Philips N.V. Improves Workflow and Efficiency with Next Generation Ultrasound Systems EPIQ Elite and Affiniti at RSNA23

Philips Launches New-AI Enabled Innovations at #RSNA23 That Free Up Healthcare Providers to Focus on Patient Care

Royal Philips Announces Latest Results Demonstrating the Safety of Philips Instant Wave-Free Ratio (iFR) in the Guidance of PCI

Koninklijke Philips N.V. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Koninklijke Philips (AMS:PHIA) Is Making Moderate Use Of Debt

Royal Philips and US Subsidiaries Including Philips Respironics Reach an Agreement to Resolve All Economic Loss Claims in the US Multidistrict Litigation

Exor N.V. (ENXTAM:EXO) acquired 15% stake in Koninklijke Philips N.V. (ENXTAM:PHIA).

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies